Haystack’s co-founder and Chief Innovation Officer, Josh Cohen, will be participating in a panel discussion at the upcoming Precision Medicine World Conference (PMWC) in Silicon Valey, CA. The panel, “Liquid Biopsy for Minimal Residual Disease,” will take place on January 26 and will bring together recognized leaders in the MRD field. With over 2,500 attendees from around the world, PMWC is the foremost precision medicine conference, promoting collaboration and knowledge-sharing among top global researchers, medical professionals, and biotech.
PMWC panel discussion
Title: Liquid Biopsy for Minimal Residual Disease
Track: 4
Date: January 26, 2023
Time: 3:30pm – 4:15pm Pacific
Location: Santa Clara, CA
